Author:
Auvray Marie,Baylot Camille,Blanc-Durand Félix,Borcoman Edith,Pons-Tostivint Elvire,Vignot Stéphane
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference50 articles.
1. A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with RET-altered cancers;Drilon;J Clin Oncol,2018
2. On the Origin of Cancer Cells;Warburg;Science,1956
3. First-in-human phase I study of JPH203, L-type amino acids transporter 1 inhibitor, in patients with advanced solid tumors;Okano;J Clin Oncol,2018
4. First-in-human, first-in-class phase 1a study of BXQ-350 for solid tumors and gliomas;Rixe;J Clin Oncol,2018
5. A first-in-human phase 1 dose-escalation trial of the oral HIF-2a inhibitor PT2977 in patients with advanced solid tumors;Papadopoulos;J Clin Oncol,2018